SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from BIONOVO, INC. (CIK 0001203957) — Nov 2, 2005

BIONOVO, INC. (CIK 0001203957)
Date: Nov. 2, 2005 · CIK: 0001203957 · Accession: 0001144204-05-033578

AI Filing Summary & Sentiment

File numbers found in text: 333-126399

Date
Nov. 2, 2005
Author
BIONOVO
Form
CORRESP
Company
BIONOVO, INC. (CIK 0001203957)

Letter

Unassociated Document

[Bionovo Letterhead--graphic omitted]

November 2, 2005

VIA EDGAR

U.S. Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Zafar Hasan

Mail Stop: 6010

Re: Bionovo, Inc.

Registration Statement on Form SB-2

Commission File No. 333-126399

Ladies and Gentlemen:

In connection with the request for acceleration previously submitted by Bionovo, Inc. (the “Company”) with respect to the above-referenced registration statement, the Company hereby acknowledges the following: (i) should the Securities and Exchange Commission (the “Commission”) or its staff (the “Staff”), acting pursuant to delegated authority, declare the above-referenced registration statement effective, it does not foreclose the Commission from taking any action with respect to the above-referenced registration statement; (ii) the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the above-referenced registration statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the above-referenced registration statement; and (iii) the Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
BIONOVO,
INC.

Show Raw Text
CORRESP
1
filename1.htm

      Unassociated Document

      [Bionovo
        Letterhead--graphic omitted]

      November
        2, 2005

      VIA
        EDGAR

      U.S.
        Securities and Exchange Commission

      100
        F
        Street, N.E.

      Washington,
        D.C. 20549

      Attention:
        Zafar
        Hasan

      Mail
        Stop: 6010

      Re:  Bionovo,
        Inc.

      Registration
        Statement on Form SB-2

      Commission
        File No. 333-126399

      Ladies
        and Gentlemen:

      In
        connection with the request for acceleration previously submitted by Bionovo,
        Inc. (the “Company”) with respect to the above-referenced registration
        statement, the Company hereby acknowledges the following: (i) should the
        Securities and Exchange Commission (the “Commission”) or its staff (the
“Staff”), acting pursuant to delegated authority, declare the above-referenced
        registration statement effective, it does not foreclose the Commission from
        taking any action with respect to the above-referenced registration statement;
        (ii) the action of the Commission or the Staff, acting pursuant to delegated
        authority, in declaring the above-referenced registration statement effective,
        does not relieve the Company from its full responsibility for the adequacy
        and
        accuracy of the disclosure in the above-referenced registration statement;
        and
        (iii) the Company may not assert this action as a defense in any proceeding
        initiated by the Commission or any person under the federal securities laws
        of
        the United States.

                                      Sincerely,

                                      BIONOVO,
        INC.

                                      /s/
        Isaac
        Cohen

                                      Isaac
        Cohen

                                      President
        and Chief
        Executive Officer